Free Trial

Oramed Pharmaceuticals (ORMP) Institutional Ownership

Oramed Pharmaceuticals logo
$2.15 -0.05 (-2.27%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$2.15 +0.00 (+0.23%)
As of 04/17/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Oramed Pharmaceuticals (NASDAQ:ORMP)

Current
Institutional Ownership
Percentage
12.73%
Number of
Institutional Buyers
(last 12 months)
12
Total
Institutional Inflows
(last 12 months)
$6.61M
Number of
Institutional Sellers
(last 12 months)
10
Total
Institutional Outflows
(last 12 months)
$3.08M
Get ORMP Insider Trade Alerts

Want to know when executives and insiders are buying or selling Oramed Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ORMP Institutional Buying and Selling by Quarter

Oramed Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/17/2025Squarepoint Ops LLC54,439$132K0.0%-34.7%0.135%
2/17/2025Two Sigma Investments LP110,378$267K0.0%-22.1%0.274%
2/17/2025Two Sigma Advisers LP241,400$584K0.0%-5.6%0.599%
2/17/2025Millennium Management LLC24,381$59K0.0%-47.8%0.060%
2/17/2025Bank of America Corp DE167,653$406K0.0%-2.6%0.416%
2/14/2025Jane Street Group LLC49,663$120K0.0%-14.8%0.123%
2/14/2025Boothbay Fund Management LLC845,188$2.05M0.1%+2.0%2.097%
2/14/2025Dimensional Fund Advisors LP118,995$288K0.0%+143.8%0.295%
2/13/2025Renaissance Technologies LLC151,808$367K0.0%-38.1%0.377%
2/11/2025LPL Financial LLC17,431$42K0.0%-54.9%0.043%
2/7/2025BML Capital Management LLC2,643,907$6.40M4.0%+20.9%6.559%
2/4/2025World Equity Group Inc.20,000$48K0.0%N/A0.050%
1/29/2025Peapod Lane Capital LLC227,239$550K0.5%N/A0.564%
1/14/2025 Marquette Asset Management LLC33,311$81K0.0%N/A0.083%
11/15/2024XTX Topco Ltd24,716$60K0.0%+59.7%0.061%
11/15/2024Murchinson Ltd.1,708,879$4.17M1.1%+0.5%4.239%
11/8/2024Connor Clark & Lunn Investment Management Ltd.111,519$272K0.0%N/A0.274%
11/5/2024BML Capital Management LLC2,186,191$5.33M3.1%+62.1%5.362%
8/16/2024Murchinson Ltd.1,699,990$4.37M0.7%+23.2%4.184%
8/14/2024Squarepoint Ops LLC81,758$210K0.0%-8.3%0.201%
8/14/2024Murchinson Ltd.874,992$2.25M0.4%-36.6%2.154%
8/12/2024XTX Topco Ltd15,474$40K0.0%N/A0.038%
8/9/2024Renaissance Technologies LLC230,800$593K0.0%+89.0%0.568%
8/9/2024Dimensional Fund Advisors LP31,470$81K0.0%+52.1%0.077%
5/20/2024Virtu Financial LLC23,165$68K0.0%N/A0.057%
5/16/2024Murchinson Ltd.1,379,495$4.03M0.3%+31.4%3.395%
4/24/2024 Assenagon Asset Management S.A.18,659$54K0.0%N/A0.046%
4/23/2024BML Capital Management LLC844,496$2.47M1.6%-33.1%2.084%
1/30/2024BML Capital Management LLC1,261,559$2.91M2.2%+61.5%3.127%
11/13/2023Algert Global LLC14,680$38K0.0%N/A0.036%
11/13/2023Rathbones Group PLC289,803$756K0.0%N/A0.718%
11/7/2023Barclays PLC18,406$47K0.0%+39.0%0.046%
11/6/2023N.E.W. Advisory Services LLC12,960$34K0.0%N/A0.032%
10/23/2023BML Capital Management LLC781,292$2.04M1.9%-8.1%1.940%
9/21/2023Barclays PLC13,239$47K0.0%-35.9%0.033%
8/7/2023Acadian Asset Management LLC31,736$113K0.0%N/A0.079%
7/26/2023 Glass Jacobson Investment Advisors llc12,255$44K0.0%N/A0.031%
7/24/2023BML Capital Management LLC850,000$3.04M2.7%-37.3%2.123%
5/12/2023Corsair Capital Management L.P.47,256$103K0.0%N/A0.119%
4/18/2023ETF Managers Group LLC68,940$150K0.0%N/A0.173%
Musk’s AI Masterplan – Our #1 AI Stock to Buy Now (Ad)

Did Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so. Musk has been quietly creating one of the most ambitious AI ventures in history.

For all the details - including the name and ticker of our #1 AI stock to buy right now - click here
4/14/2023BML Capital Management LLC1,355,925$2.96M2.6%N/A3.409%
2/14/2023683 Capital Management LLC20,537$247K0.0%N/A0.052%
2/13/2023GSA Capital Partners LLP46,039$554K0.1%N/A0.118%
2/9/2023Landscape Capital Management L.L.C.26,220$315K0.0%N/A0.067%
2/9/2023Citigroup Inc.65,890$793K0.0%+115.0%0.168%
2/8/2023Belpointe Asset Management LLC29,900$360K0.0%N/A0.076%
2/8/2023Russell Investments Group Ltd.56,516$680K0.0%N/A0.144%
2/6/2023 Glass Jacobson Investment Advisors llc9,350$112K0.1%N/A0.024%
2/1/2023Private Portfolio Partners LLC53,600$645K0.2%-20.5%0.137%
2/1/2023 Janney Montgomery Scott LLC12,379$149K0.0%N/A0.032%
1/26/2023Calamos Advisors LLC14,746$177K0.0%N/A0.038%
1/25/2023Lindbrook Capital LLC383,351$4.61M0.6%N/A0.980%
1/18/2023Private Advisor Group LLC11,794$142K0.0%N/A0.030%
11/15/2022ETF Managers Group LLC94,493$612K0.0%+8.2%0.242%
11/14/2022Cubist Systematic Strategies LLC117,477$761K0.0%+66.1%0.303%
11/14/2022Ergoteles LLC24,149$156K0.0%-89.3%0.062%
11/10/2022Phoenix Holdings Ltd.13,634$89K0.0%-73.2%0.035%
11/7/2022Virtu Financial LLC21,526$139K0.0%-19.3%0.055%
11/7/2022Private Portfolio Partners LLC67,400$437K0.1%+24.8%0.174%
11/3/2022Barclays PLC21,543$140K0.0%+8.7%0.055%
10/31/2022 SG Americas Securities LLC10,370$67K0.0%-77.7%0.027%
10/21/2022Morgan Jess S & Co. Inc.366,401$2.37M2.1%+16.2%0.944%
10/17/2022Cambridge Investment Research Advisors Inc.14,184$92K0.0%+26.8%0.037%
8/15/2022Laurion Capital Management LP12,393$57K0.0%N/A0.032%
8/13/2022Virtu Financial LLC26,661$122K0.0%N/A0.069%
8/11/2022Bank of Montreal Can249,200$1.35M0.0%N/A0.646%
8/8/2022Oppenheimer & Co. Inc.50,000$229K0.0%+5.4%0.130%
8/2/2022Private Portfolio Partners LLC54,010$247K0.1%+27.8%0.140%
7/29/2022 SG Americas Securities LLC46,532$213K0.0%N/A0.121%
7/21/2022Belvedere Trading LLC40,690$343K0.0%N/A0.106%
7/19/2022Commonwealth Equity Services LLC29,514$135K0.0%+7.1%0.077%
7/18/2022Morgan Jess S & Co. Inc.315,301$1.44M1.5%+8.5%0.818%
7/13/2022Cambridge Investment Research Advisors Inc.11,184$51K0.0%N/A0.029%
6/30/2022Amalgamated Bank6,457$56K0.0%N/A0.017%
5/16/2022Morgan Jess S & Co. Inc.290,501$2.51M1.8%+34.9%0.759%
5/12/2022Private Portfolio Partners LLC42,250$365K0.1%N/A0.110%
5/12/2022Oppenheimer & Co. Inc.47,450$410K0.0%+18.6%0.124%
5/10/2022Phoenix Holdings Ltd.28,155$244K0.0%-10.1%0.074%
5/9/2022Rossmore Private Capital40,661$352K0.1%-21.8%0.106%
5/9/2022Qube Research & Technologies Ltd56,348$487K0.0%-13.0%0.147%
5/5/2022Russell Investments Group Ltd.43,013$371K0.0%-55.7%0.112%
5/3/2022Calamos Advisors LLC38,071$330K0.0%-65.9%0.099%
4/25/2022 Assenagon Asset Management S.A.385,413$3.33M0.0%N/A1.007%
4/21/2022Strs Ohio5,400$46K0.0%-41.9%0.014%
3/3/2022Walleye Capital LLC36,740$525K0.0%N/A0.096%
2/14/2022Point72 Hong Kong Ltd2,132$30K0.0%N/A0.006%
2/14/2022ETF Managers Group LLC53,153$729K0.0%+6.5%0.139%
2/14/2022Rockefeller Capital Management L.P.4,000$57K0.0%N/A0.010%
2/11/2022Renaissance Technologies LLC203,200$2.90M0.0%N/A0.531%
2/10/2022Qube Research & Technologies Ltd64,799$925K0.0%N/A0.169%
Trump to unlock 15-figure fortune for America (May 3rd) ? (Ad)

We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America. Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking. And he believes Trump could soon release this frozen asset to the public.

But something even more spectacular is bound to happen. And those who know what to expect could make
2/10/2022OLD Mission Capital LLC38,691$553K0.0%N/A0.101%
2/10/2022HighTower Advisors LLC14,000$199K0.0%-50.0%0.037%
2/10/2022Connor Clark & Lunn Investment Management Ltd.50,786$725K0.0%+96.4%0.133%
2/9/2022BNP Paribas Arbitrage SA20,266$289K0.0%+275.9%0.053%
2/9/2022 UMB Bank N A MO8,080$116K0.0%N/A0.021%
2/8/2022Swiss National Bank64,400$920K0.0%N/A0.168%
2/8/2022Northern Trust Corp243,125$3.47M0.0%+7.7%0.635%
2/7/2022Victory Capital Management Inc.13,310$190K0.0%N/A0.035%
2/7/2022 SG Americas Securities LLC8,631$123K0.0%-36.3%0.023%
2/7/2022Phoenix Holdings Ltd.31,328$439K0.0%+9.5%0.082%
(Data available from 1/1/2016 forward)

ORMP Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ORMP shares?

During the previous two years, 27 institutional investors and hedge funds held shares of Oramed Pharmaceuticals. The most heavily invested institutionals were BML Capital Management LLC ($6.40M), Murchinson Ltd. ($4.17M), Boothbay Fund Management LLC ($2.05M), Rathbones Group PLC ($756K), Two Sigma Advisers LP ($584K), Peapod Lane Capital LLC ($550K), and Bank of America Corp DE ($406K).Learn more on ORMP's institutional investors.

What percentage of Oramed Pharmaceuticals stock is owned by institutional investors?

12.73% of Oramed Pharmaceuticals stock is owned by institutional investors. Learn more on ORMP's institutional investor holdings.

Which institutional investors have been buying Oramed Pharmaceuticals stock?

Of the 20 institutional investors that purchased Oramed Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BML Capital Management LLC ($1.78M), Murchinson Ltd. ($658.88K), Rathbones Group PLC ($289.80K), Peapod Lane Capital LLC ($227.24K), Connor Clark & Lunn Investment Management Ltd. ($111.52K), Renaissance Technologies LLC ($108.70K), and Dimensional Fund Advisors LP ($80.96K).

How much institutional buying is happening at Oramed Pharmaceuticals?

Institutional investors have bought a total of 3,581,942 shares in the last 24 months. This purchase volume represents approximately $8.97M in transactions.

Which Oramed Pharmaceuticals major shareholders have been selling company stock?

Of the 11 institutional investors that sold Oramed Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: BML Capital Management LLC ($991.70K), Murchinson Ltd. ($504.50K), Renaissance Technologies LLC ($93.49K), Squarepoint Ops LLC ($36.28K), Two Sigma Investments LP ($31.31K), Millennium Management LLC ($22.29K), and LPL Financial LLC ($21.25K).

How much institutional selling is happening at Oramed Pharmaceuticals?

Institutional investors have sold a total of 1,735,601 shares in the last 24 months. This volume of shares sold represents approximately $5.09M in transactions.



This page (NASDAQ:ORMP) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners